These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 7029283)
61. [Effect of ustimon on cerebral circulation]. Vas M; Solti F; Gara I Wien Klin Wochenschr; 1969 Jan; 81(4):69-72. PubMed ID: 5812950 [No Abstract] [Full Text] [Related]
69. [Indications for Ustimon and Instenon therapy in cerebrovascular diseases]. Eichhorn O Wien Klin Wochenschr; 1967 Jan; 79(4):67-71. PubMed ID: 5340281 [No Abstract] [Full Text] [Related]
70. [Can psychiatric disorders on the aged be influenced by affecting the cerebral circulation?]. Lambert PA; Bouchardy M Sem Ther; 1968 Dec; 44(10):654-5. PubMed ID: 5706292 [No Abstract] [Full Text] [Related]
71. [Treatment of acute cerebrovascular insufficiency using Instenon]. Eichhorn O Wien Klin Wochenschr; 1969 Oct; 81(40):697-700. PubMed ID: 5344304 [No Abstract] [Full Text] [Related]
72. [Experience with Cosaldon retard in double blind studies]. Dreyer H; Keussen M; Wojtek L Dtsch Med J; 1969 May; 20(10):356-8. PubMed ID: 4919479 [No Abstract] [Full Text] [Related]
73. [Treatment by medicine which improves cerebral circulation and metabolism]. Katsumata T; Katayama Y Nihon Rinsho; 2006 Nov; 64 Suppl 8():81-4. PubMed ID: 17469538 [No Abstract] [Full Text] [Related]
74. [Attempt at classification of various special indications for 1035 MD (sureptil) in neuropsychiatry]. Bornstein S; Czermak M; Kannas S; Postel J Ann Med Psychol (Paris); 1969 Jan; 1(1):139-44. PubMed ID: 4388586 [No Abstract] [Full Text] [Related]
75. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study]. Lefebvre P; Crocq L; Bernard JG Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724 [No Abstract] [Full Text] [Related]
76. Circulatory effect of several cerebral circulatory drugs in man, with special reference to aminophylline, papaverine, cyclandelate, vincamine, prostaglandin E1 and isoxsuprine. Miyazaki M Jpn Circ J; 1978 Apr; 42(4):433-40. PubMed ID: 702768 [No Abstract] [Full Text] [Related]
77. Direct vascular effects of agents used in the pharmacotherapy of cerebrovascular disease on isolated cerebral vessels. Young AR; Bouloy M; Boussard JF; Edvinsson L; MacKenzie ET J Cereb Blood Flow Metab; 1981; 1(1):117-28. PubMed ID: 7328134 [No Abstract] [Full Text] [Related]
78. Effect of cerebral circulatory drugs on cerebral and peripheral circulation, with special reference to aminophylline, papaverine, cyclandelate and isoxsuprine. Miyazaki M Eur Neurol; 1971-1972; 6(1):162-5. PubMed ID: 5153420 [No Abstract] [Full Text] [Related]
79. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy. Man'kovsky NB; Minz AY Gerontology; 1988; 34(1-2):75-81. PubMed ID: 3384341 [TBL] [Abstract][Full Text] [Related]
80. Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia. Albizzati MG; Bassi S; Calloni E; Sbacchi M; Piolti R; Frattola L Drugs; 1987; 33 Suppl 2():90-6. PubMed ID: 3304956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]